BEKE-W
02423
TME-SW
01698
JD HEALTH
06618
JD-SW
09618
NTES-S
09999
(FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | (Q6)Jun 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -24.39%13.2B | 40.90%3.29B | 69.40%17.45B | 7.29%2.33B | -27.37%10.3B | -56.50%2.17B | ---- | -15.99%14.18B | ---- | -11.86%5B |
Operating income | -24.39%13.2B | 40.90%3.29B | 69.40%17.45B | 7.29%2.33B | -27.37%10.3B | -56.50%2.17B | -15.99%14.18B | -11.86%5B | ||
Cost of sales | 22.19%-10.77B | -57.45%-2.73B | -73.74%-13.84B | -63.56%-1.73B | 29.51%-7.97B | 70.30%-1.06B | ---- | -10.21%-11.3B | ---- | 2.01%-3.57B |
Operating expenses | 22.19%-10.77B | -57.45%-2.73B | -73.74%-13.84B | -63.56%-1.73B | 29.51%-7.97B | 70.30%-1.06B | -10.21%-11.3B | 2.01%-3.57B | ||
Gross profit | -32.82%2.43B | -6.97%557.41M | 54.62%3.61B | -46.23%599.18M | -18.98%2.34B | -22.03%1.11B | -56.50%2.88B | -29.54%1.43B | ||
Administrative expenses | 18.02%-104.61M | 28.81%-39M | 36.32%-127.6M | -11.89%-54.79M | -15.87%-200.38M | -10.21%-48.96M | ---- | 11.75%-172.94M | ---- | 9.59%-44.43M |
Revaluation surplus | -95.30%28.72M | -102.36%-6.21M | -58.69%610.54M | 1,006.50%263.6M | -9.31%1.48B | --23.82M | ---- | 3,049.71%1.63B | ---- | ---- |
-Changes in the fair value of investment property | -89.07%66.86M | ---- | -57.45%611.42M | --243M | -1.86%1.44B | ---- | ---- | 1,608.97%1.46B | ---- | ---- |
-Changes in the fair value of financial assets | -4,238.45%-38.14M | -130.15%-6.21M | -102.15%-879K | -13.52%20.6M | -75.29%40.85M | --23.82M | ---- | 217.31%165.32M | ---- | ---- |
Impairment and provision | -31.05%-961.13M | -1,238.05%-561.09M | -12.40%-733.41M | ---41.93M | ---652.48M | ---- | ---- | ---- | ---- | ---- |
-Impairment of property, machinery and equipment | -36.62%-556.82M | ---279.37M | 31.86%-407.56M | ---- | ---598.13M | ---- | ---- | ---- | ---- | ---- |
-Other impairment is provision | -24.08%-404.31M | -571.83%-281.72M | -499.54%-325.86M | ---41.93M | ---54.35M | ---- | ---- | ---- | ---- | ---- |
Operating interest expense | 13.85%-1.16B | ---- | -20.51%-1.35B | ---- | -28.54%-1.12B | -19.18%-467.66M | ---- | -33.34%-868.58M | ---- | ---392.41M |
Special items of operating profit | -1,195.10%-1.36B | -824.31%-273.5M | 124.07%124.36M | 119.38%37.76M | -239.58%-516.68M | 13.50%-194.84M | --14.56B | 190.26%370.18M | --58.63B | 0.11%-225.25M |
Operating profit | -152.80%-1.13B | -140.11%-322.39M | 61.19%2.14B | 88.41%803.82M | -65.42%1.33B | -44.37%426.64M | -27.74%3.84B | -51.50%766.95M | ||
Financing cost | ---- | 10.49%-613.05M | ---- | ---684.88M | ---- | ---- | ---- | ---- | ---- | ---- |
Share of profits of associates | -25.32%-288.93M | -20,067.85%-193.81M | -141.40%-230.56M | -100.19%-961K | -18.50%556.95M | 66.44%510.75M | ---- | 548.66%683.37M | ---- | 906.56%306.87M |
Share of profit from joint venture company | -1,561.53%-2.09B | -330.19%-1.17B | -107.85%-125.75M | -25.06%507.79M | 33.80%1.6B | -9.72%677.58M | ---- | -35.01%1.2B | ---- | -26.47%750.57M |
Earning before tax | -296.58%-3.51B | -467.25%-2.3B | -48.83%1.79B | -61.25%625.77M | -39.05%3.49B | -11.48%1.61B | -21.23%5.72B | -20.32%1.82B | ||
Tax | 30.88%-658.25M | 883.78%145.89M | 15.08%-952.28M | 96.17%-18.61M | 19.59%-1.12B | 9.17%-485.4M | ---- | 42.64%-1.39B | ---- | 6.42%-534.43M |
After-tax profit from continuing operations | -600.42%-4.17B | -454.48%-2.15B | -64.81%832.75M | -46.25%607.16M | -45.33%2.37B | -12.43%1.13B | -10.46%4.33B | -24.94%1.29B | ||
Earning after tax | -600.42%-4.17B | -454.48%-2.15B | -64.81%832.75M | -46.25%607.16M | -45.33%2.37B | -12.43%1.13B | -10.46%4.33B | -24.94%1.29B | ||
Minority profit | -17.66%403.5M | -39.86%26.87M | 1,043.39%490.03M | 0.27%44.67M | -86.38%42.86M | -80.06%44.55M | ---- | -34.48%314.7M | ---- | 102.63%223.46M |
Profit attributable to shareholders | -1,433.68%-4.57B | -487.41%-2.18B | -85.25%342.72M | -48.16%562.48M | -42.11%2.32B | 1.74%1.09B | -7.82%4.01B | -33.69%1.07B | ||
Basic earnings per share | -1,435.44%-0.2751 | -487.02%-0.1312 | -85.29%0.0206 | -48.17%0.0339 | -42.27%0.14 | 1.40%0.0654 | -9.48%0.2425 | -35.76%0.0645 | ||
Diluted earnings per share | -1,435.44%-0.2751 | -488.17%-0.1312 | -85.26%0.0206 | -48.24%0.0338 | -42.06%0.1398 | 1.87%0.0653 | -8.49%0.2413 | -35.58%0.0641 | ||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | Ernst & Young | -- | Ernst & Young | -- | -- | Ernst & Young | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Unlock the Full List